Clinical Applicable AI System Based on Deep Learning Algorithm for Differentiation of Pulmonary Infectious Disease

To assess the performance of a novel deep learning (DL)-based artificial intelligence (AI) system in classifying computed tomography (CT) scans of pneumonia patients into different groups, as well as to present an effective clinically relevant machine learning (ML) system based on medical image iden...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in medicine Vol. 8; p. 753055
Main Authors Zhang, Yu-Han, Hu, Xiao-Fei, Ma, Jie-Chao, Wang, Xian-Qi, Luo, Hao-Ran, Wu, Zi-Feng, Zhang, Shu, Shi, De-Jun, Yu, Yi-Zhou, Qiu, Xiao-Ming, Zeng, Wen-Bing, Chen, Wei, Wang, Jian
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 03.12.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To assess the performance of a novel deep learning (DL)-based artificial intelligence (AI) system in classifying computed tomography (CT) scans of pneumonia patients into different groups, as well as to present an effective clinically relevant machine learning (ML) system based on medical image identification and clinical feature interpretation to assist radiologists in triage and diagnosis. The 3,463 CT images of pneumonia used in this multi-center retrospective study were divided into four categories: bacterial pneumonia ( = 507), fungal pneumonia ( = 126), common viral pneumonia ( = 777), and COVID-19 ( = 2,053). We used DL methods based on images to distinguish pulmonary infections. A machine learning (ML) model for risk interpretation was developed using key imaging (learned from the DL methods) and clinical features. The algorithms were evaluated using the areas under the receiver operating characteristic curves (AUCs). The median AUC of DL models for differentiating pulmonary infection was 99.5% (COVID-19), 98.6% (viral pneumonia), 98.4% (bacterial pneumonia), 99.1% (fungal pneumonia), respectively. By combining chest CT results and clinical symptoms, the ML model performed well, with an AUC of 99.7% for SARS-CoV-2, 99.4% for common virus, 98.9% for bacteria, and 99.6% for fungus. Regarding clinical features interpreting, the model revealed distinctive CT characteristics associated with specific pneumonia: in COVID-19, ground-glass opacity (GGO) [92.5%; odds ratio (OR), 1.76; 95% confidence interval (CI): 1.71-1.86]; larger lesions in the right upper lung (75.0%; OR, 1.12; 95% CI: 1.03-1.25) with viral pneumonia; older age (57.0 years ± 14.2, OR, 1.84; 95% CI: 1.73-1.99) with bacterial pneumonia; and consolidation (95.8%, OR, 1.29; 95% CI: 1.05-1.40) with fungal pneumonia. For classifying common types of pneumonia and assessing the influential factors for triage, our AI system has shown promising results. Our ultimate goal is to assist clinicians in making quick and accurate diagnoses, resulting in the potential for early therapeutic intervention.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Reza Lashgari, Shahid Beheshti University, Iran
Reviewed by: Giulia Besutti, AUSL Reggio Emilia, Italy; Bertrand De Meulder, European Institute for Systems Biology and Medicine (EISBM), France
This article was submitted to Infectious Diseases - Surveillance, Prevention and Treatment, a section of the journal Frontiers in Medicine
These authors have contributed equally to this work and share first authorship
ISSN:2296-858X
2296-858X
DOI:10.3389/fmed.2021.753055